Hong Kong, China

Wai Tung Leung

This inventor holds 5 USPTO granted patents. Top assignee: The Hong Kong University of Science and Technology. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wai Tung Leung. Retrieved from https://idiyas.com/inventor/wai-tung-leung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Wai Tung Leung in Cancer Treatment

Introduction

Wai Tung Leung is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer treatment through his innovative research and development of advanced luminogenic probes. With a total of 5 patents, his work focuses on enhancing the visualization and treatment of cancer cells.

Latest Patents

One of his latest patents involves AIE luminogens for visualization and treatment of cancer. This subject matter relates to AIE luminogenic probes designed for cancer cell visualization and discrimination. It includes lysosome-targeting AIEgens for imaging and autophagy visualization, as well as highly fluorescent AIE-active theranostic agents that monitor drug distribution and exhibit anti-tumor activity against specific cancer cells. Additionally, he has developed probes comprising AIE luminogens for cancer cell imaging and staining, which feature clusteroluminogenic properties and methods of preparation.

Another significant patent focuses on the specific detection and quantification of cardiolipin and isolated mitochondria using positively charged AIE fluorogens. This one-step method allows for the detection and quantification of cardiolipin in a sample by measuring the fluorescence intensity after introducing the AIE luminogen. It also includes methods for quantifying isolated mitochondria, enhancing sensitivity and selectivity in detecting cardiolipin over other major mitochondrial membrane lipids.

Career Highlights

Wai Tung Leung is affiliated with The Hong Kong University of Science and Technology, where he continues to advance his research in the field of cancer treatment. His innovative approaches have garnered attention and recognition within the scientific community.

Collaborations

He has collaborated with notable researchers such as Benzhong Tang and Yuning Hong, contributing to the advancement of knowledge in his field.

Conclusion

Wai Tung Leung's innovative work in developing AIE luminogens has the potential to significantly impact cancer treatment and diagnostics. His contributions reflect a commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…